Tharmalingam H - Search Results

1

Changes in Magnetic Resonance Imaging Radiomic Features in Response to Androgen Deprivation Therapy in Patients with Intermediate- and High-risk Prostate Cancer.

Tharmalingam H, Tsang YM, Alonzi R, Beasley W, Taylor NJ, McWilliam A, Padhani A, Choudhury A, Hoskin PJ. Tharmalingam H, et al. Clin Oncol (R Coll Radiol). 2022 Jun;34(6):e246-e253. doi: 10.1016/j.clon.2021.12.020. Epub 2022 Jan 13. Clin Oncol (R Coll Radiol). 2022. PMID: 35033410

2

The optimism surrounding stereotactic body radiation therapy and immunomodulation.

Tharmalingam H, Hoskin PJ. Tharmalingam H, et al. Chin Clin Oncol. 2017 Sep;6(Suppl 2):S9. doi: 10.21037/cco.2017.05.01. Chin Clin Oncol. 2017. PMID: 28917247 Free article. Review.

3

Relapsing Prostate Cancer: Castrate or Cure?

Tharmalingam H, Choudhury A. Tharmalingam H, et al. Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1095-1096. doi: 10.1016/j.ijrobp.2018.01.100. Int J Radiat Oncol Biol Phys. 2018. PMID: 29722651 No abstract available.

4

UK Training in Clinical Oncology: Tasters, Coasters and the National Recruitment Crisis.

Tharmalingam H, Vinayan A, Anyamene N. Tharmalingam H, et al. Clin Oncol (R Coll Radiol). 2018 Oct;30(10):599-601. doi: 10.1016/j.clon.2018.07.021. Epub 2018 Jul 24. Clin Oncol (R Coll Radiol). 2018. PMID: 30054127 No abstract available.

5

The Role of Magnetic Resonance Imaging in Brachytherapy.

Tharmalingam H, Alonzi R, Hoskin PJ. Tharmalingam H, et al. Clin Oncol (R Coll Radiol). 2018 Nov;30(11):728-736. doi: 10.1016/j.clon.2018.07.024. Epub 2018 Jul 31. Clin Oncol (R Coll Radiol). 2018. PMID: 30075902 Review.

6

New approaches for effective and safe pelvic radiotherapy in high-risk prostate cancer.

Tharmalingam H, Choudhury A, Van Herk M, McWilliam A, Hoskin PJ. Tharmalingam H, et al. Nat Rev Urol. 2019 Sep;16(9):523-538. doi: 10.1038/s41585-019-0213-3. Epub 2019 Jul 25. Nat Rev Urol. 2019. PMID: 31346291 Review.

7

External Beam Radiation Therapy (EBRT) and High-Dose-Rate (HDR) Brachytherapy for Intermediate and High-Risk Prostate Cancer: The Impact of EBRT Volume.

Tharmalingam H, Tsang Y, Choudhury A, Alonzi R, Wylie J, Ahmed I, Henry A, Heath C, Hoskin PJ. Tharmalingam H, et al. Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):525-533. doi: 10.1016/j.ijrobp.2019.09.044. Epub 2019 Oct 11. Int J Radiat Oncol Biol Phys. 2020. PMID: 31610249 Free article.

8

Single-Dose Focal Salvage High Dose Rate Brachytherapy for Locally Recurrent Prostate Cancer.

Chitmanee P, Tsang Y, Tharmalingam H, Hamada M, Alonzi R, Ostler P, Hughes R, Lowe G, Hoskin P. Chitmanee P, et al. Among authors: tharmalingam h. Clin Oncol (R Coll Radiol). 2020 Apr;32(4):259-265. doi: 10.1016/j.clon.2019.10.008. Epub 2019 Nov 7. Clin Oncol (R Coll Radiol). 2020. PMID: 31708350

9

A pilot study on dosimetric and radiomics analysis of urethral strictures following HDR brachytherapy as monotherapy for localized prostate cancer.

Tsang YM, Vignarajah D, Mcwilliam A, Tharmalingam H, Lowe G, Choudhury A, Hoskin P. Tsang YM, et al. Among authors: tharmalingam h. Br J Radiol. 2020 Feb 1;93(1106):20190760. doi: 10.1259/bjr.20190760. Epub 2019 Dec 2. Br J Radiol. 2020. PMID: 31778319 Free PMC article.

10

Single dose high-dose rate (HDR) brachytherapy (BT) as monotherapy for localised prostate cancer: Early results of a UK national cohort study.

Tharmalingam H, Tsang Y, Ostler P, Wylie J, Bahl A, Lydon A, Ahmed I, Elwell C, Nikapota AR, Hoskin PJ; National UK HDR Prostate Brachytherapy Database. Tharmalingam H, et al. Radiother Oncol. 2020 Feb;143:95-100. doi: 10.1016/j.radonc.2019.12.017. Epub 2020 Feb 7. Radiother Oncol. 2020. PMID: 32044166

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters